You are here

  • Home
  • Archive
  • Volume 80, Issue 5
  • Response to: ‘Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab’ by Schulze-Koops et al

Article metrics

Article menu
Download PDFPDF
Correspondence response
Response to: ‘Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab’ by Schulze-Koops et al

 

Online download statistics by month:

Online download statistics by month: June 2020 to March 2024

AbstractFullPdf
Jun 202033733492
Jul 2020369367171
Aug 202013513338
Sep 2020776836
Oct 2020576119
Nov 2020515122
Dec 2020444419
Jan 2021393821
Feb 2021403921
Mar 2021393920
Apr 202121321332
May 2021949234
Jun 2021505011
Jul 2021394021
Aug 2021373815
Sep 2021454622
Oct 2021464833
Nov 2021222116
Dec 202121205
Jan 2022252519
Feb 202224245
Mar 202225234
Apr 202219198
May 2022282811
Jun 202231315
Jul 202220224
Aug 202227275
Sep 202221216
Oct 202223238
Nov 202218184
Dec 20229104
Jan 2023171718
Feb 202329275
Mar 202313124
Apr 20232002
May 20232800
Jun 20231910
Jul 20232200
Aug 20232001
Sep 20232402
Oct 20234311
Nov 20234011
Dec 20234411
Jan 20245021
Feb 20242900
Mar 20242930
Total24522078767